Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Prr14l | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Prr14l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRR14L mRNA | CTD | PMID:36331819 | Prr14l | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Prr14l (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRR14L mRNA | CTD | PMID:22206623 | Prr14l | Rat | 17beta-estradiol | increases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Estradiol results in increased expression of PRR14L mRNA | CTD | PMID:23019147 | Prr14l | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PRR14L mRNA | CTD | PMID:32145629 | Prr14l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRR14L mRNA | CTD | PMID:33387578 | Prr14l | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PRR14L mRNA | CTD | PMID:30851411 | Prr14l | Rat | aflatoxin B1 | increases methylation | ISO | PRR14L (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of PRR14L gene | CTD | PMID:27153756 | Prr14l | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of PRR14L mRNA | CTD | PMID:30047161 | Prr14l | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of PRR14L mRNA | CTD | PMID:30779732 | Prr14l | Rat | antirheumatic drug | affects expression | ISO | PRR14L (Homo sapiens) | 6480464 | Antirheumatic Agents affects the expression of PRR14L mRNA | CTD | PMID:24449571 | Prr14l | Rat | aristolochic acid A | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of PRR14L mRNA | CTD | PMID:33212167 | Prr14l | Rat | aristolochic acid A | increases expression | ISO | PRR14L (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PRR14L protein | CTD | PMID:33212167 | Prr14l | Rat | atrazine | increases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Atrazine results in increased expression of PRR14L mRNA | CTD | PMID:22378314 | Prr14l | Rat | beta-lapachone | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of PRR14L mRNA | CTD | PMID:38218311 | Prr14l | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PRR14L mRNA | CTD | PMID:25181051 | Prr14l | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PRR14L mRNA | CTD | PMID:30816183 and PMID:32145629 | Prr14l | Rat | caffeine | affects phosphorylation | ISO | PRR14L (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of PRR14L protein | CTD | PMID:35688186 | Prr14l | Rat | chlorpyrifos | decreases expression | ISO | Prr14l (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of PRR14L mRNA | CTD | PMID:37019170 | Prr14l | Rat | cisplatin | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of PRR14L mRNA | CTD | PMID:27594783 | Prr14l | Rat | coumarin | decreases phosphorylation | ISO | PRR14L (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of PRR14L protein | CTD | PMID:35688186 | Prr14l | Rat | crocidolite asbestos | decreases expression | ISO | Prr14l (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of PRR14L mRNA | CTD | PMID:29279043 | Prr14l | Rat | dicrotophos | increases expression | ISO | PRR14L (Homo sapiens) | 6480464 | dicrotophos results in increased expression of PRR14L mRNA | CTD | PMID:28302478 | Prr14l | Rat | dorsomorphin | multiple interactions | ISO | PRR14L (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Prr14l | Rat | doxorubicin | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PRR14L mRNA | CTD | PMID:29803840 | Prr14l | Rat | epoxiconazole | decreases expression | ISO | Prr14l (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of PRR14L mRNA | CTD | PMID:35436446 | Prr14l | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of PRR14L mRNA | CTD | PMID:24136188 | Prr14l | Rat | folic acid | multiple interactions | ISO | Prr14l (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRR14L mRNA | CTD | PMID:22206623 | Prr14l | Rat | formaldehyde | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of PRR14L mRNA | CTD | PMID:20655997 | Prr14l | Rat | FR900359 | decreases phosphorylation | ISO | PRR14L (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of PRR14L protein | CTD | PMID:37730182 | Prr14l | Rat | geldanamycin | increases expression | ISO | PRR14L (Homo sapiens) | 6480464 | geldanamycin results in increased expression of PRR14L mRNA | CTD | PMID:26705709 | Prr14l | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of PRR14L mRNA | CTD | PMID:33387578 | Prr14l | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of PRR14L mRNA | CTD | PMID:28341135 | Prr14l | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of PRR14L mRNA | CTD | PMID:30047161 | Prr14l | Rat | methotrexate | increases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Methotrexate results in increased expression of PRR14L mRNA | CTD | PMID:24449571 | Prr14l | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Prr14l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRR14L mRNA | CTD | PMID:36331819 | Prr14l | Rat | phenylmercury acetate | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of PRR14L mRNA | CTD | PMID:26272509 | Prr14l | Rat | phenylmercury acetate | multiple interactions | ISO | PRR14L (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA | CTD | PMID:27188386 | Prr14l | Rat | rac-lactic acid | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PRR14L mRNA | CTD | PMID:30851411 | Prr14l | Rat | SB 431542 | multiple interactions | ISO | PRR14L (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Prr14l | Rat | thimerosal | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of PRR14L mRNA | CTD | PMID:27188386 | Prr14l | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of PRR14L mRNA | CTD | PMID:34492290 | Prr14l | Rat | trichostatin A | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of PRR14L mRNA | CTD | PMID:26272509 | Prr14l | Rat | trichostatin A | multiple interactions | ISO | PRR14L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA | CTD | PMID:27188386 | Prr14l | Rat | triphenyl phosphate | affects expression | ISO | PRR14L (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of PRR14L mRNA | CTD | PMID:37042841 | Prr14l | Rat | tungsten | decreases expression | ISO | Prr14l (Mus musculus) | 6480464 | Tungsten results in decreased expression of PRR14L mRNA | CTD | PMID:30912803 | Prr14l | Rat | valproic acid | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PRR14L mRNA | CTD | PMID:24935251 and PMID:26272509 | Prr14l | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of PRR14L mRNA | CTD | PMID:29427782 | Prr14l | Rat | valproic acid | multiple interactions | ISO | PRR14L (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA | CTD | PMID:27188386 | Prr14l | Rat | vorinostat | decreases expression | ISO | PRR14L (Homo sapiens) | 6480464 | vorinostat results in decreased expression of PRR14L mRNA | CTD | PMID:27188386 | |